Thursday, May 3, 2018

Emergent BioSolutions reports Q1 adj. EPS (3c), consensus 22c

Reports Q1 revenue $117.8M, consensus $140.42M
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.